B 796 (Rivastigmine Tartrate 6 mg)
Pill with imprint B 796 is Orange / Red, Capsule-shape and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Breckenridge Pharmaceutical, Inc.
Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B 796
Rivastigmine Tartrate
- Imprint
- B 796
- Strength
- 6 mg
- Color
- Orange / Red
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC)
- 51991-0796
- Inactive Ingredients
-
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
silicon dioxide,
gelatin,
titanium dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about rivastigmine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (34)
- Drug images
- Pricing & coupons
- Drug class: cholinesterase inhibitors
Patient resources
- Drug Information
- Rivastigmine transdermal
- Rivastigmine Transdermal (Advanced Reading)
- Rivastigmine Capsules
- Rivastigmine Oral Solution
- Rivastigmine Patch
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.